CI Private Wealth »

Homology Medicines shares owned by CI Private Wealth

Quarter-by-quarter ownership of Homology Medicines shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Homology Medicines

Tip: Access up to 7 years of quarterly data

All positions including Homology Medicines held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Homology Medicines by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.1k 10k 0.61

More positions owned by CI Private Wealth

Apple (AAPL)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
Ishares Tr Core S&p500 Etf (IVV)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
UnitedHealth (UNH)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)

View all positions for CI Private Wealth

Top funds holding Homology Medicines

5AM Venture Management
Vanguard Group
Newtyn Management
George Kaiser Family Foundation
ADAR1 Capital Management
Bank of America Corporation
Tudor Investment Corporation
Citadel Advisors
Barclays
Franklin Resources
American Investment Services
Virtu Financial
Schechter Investment Advisors
Goldman Sachs Group
Jane Street

View all funds holding Homology Medicines